United States· US:17089-231_53f5d23c-08d5-fd02-e063-6294a90a3caf

GUNA-FEM

A medicinal product containing adenosine cyclic phosphate; sus scrofa corpus luteum; sus scrofa adrenal gland; sus scrofa pituitary gland; sus scrofa hypothalamus; lilium lancifolium bulb; melatonin; sus scrofa ovary; sus scrofa pancreas; sus scrofa pineal gland; sus scrofa thymus; thyroid, registered in United States by Guna spa.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGUNA-FEMATC—REGISTER NO.US:17089-231_53f5d23c…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA CORPUS LUTEUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA HYPOTHALAMUS; LILIUM LANCIFOLIUM BULB; MELATONIN; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA THYMUS; THYROID
Manufacturer
Guna spa
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    17089-231-18

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2e7b6d2e-73b9-4911-8ebf-f73149b383f7
GET /v1/drugs/2e7b6d2e-73b9-4911-8ebf-f73149b383f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "6; 30; 30; 30; 30; 6; 200; 6; 30; 30; 30; 6",
  "substance": "ADENOSINE CYCLIC PHOSPHATE; SUS SCROFA CORPUS LUTEUM; SUS SCROFA ADRENAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA HYPOTHALAMUS; LILIUM LANCIFOLIUM BULB; MELATONIN; SUS SCROFA OVARY; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA THYMUS; THYROID",
  "productndc": "17089-231",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about adenosine cyclic phosphate; sus scrofa corpus luteum; sus scrofa adrenal gland; sus scrofa pituitary gland; sus scrofa hypothalamus; lilium lancifolium bulb; melatonin; sus scrofa ovary; sus scrofa pancreas; sus scrofa pineal gland; sus scrofa thymus; thyroid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.